Ian R. Powley

Ian R. Powley

Auto-generated profile, based on publicly available information

Ian R. Powley

Cancer Research UK Scotland Institute, Glasgow, UK

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Nature
Verified
Journal Article
Open access
PDF file
MMMiryam Müller
Miryam Müller
SMStephanie May
Stephanie May
HHHolly Hall
Holly Hall
Tim KendallTim Kendall
Tim Kendall
LMLynn McGarry
Lynn McGarry
TBThomas G. Bird
Thomas G. Bird
Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is a leading cause of cancer-related mortality worldwide1,2. HCC occurs typically from a background of chronic liver disease, caused by a spectrum of predisposing conditions. Tumour development is driven by the expansion of clones that accumulate progressive driver mutations3, with hepatocytes the most likely cell of origin2. However, the landscape of driver mutations in HCC is broadly independent of the underlying aetiologies4. Despite an increasing range of systemic treatment options for advanced HCC, outcomes remain heterogeneous and typically poor. Emerging data suggest that drug efficacies depend on disease aetiology and genetic alterations5,6. Exploring subtypes in preclinical models with human relevance will therefore be essential to advance precision medicine in HCC7. Here we generated a suite of genetically driven immunocompetent in vivo and matched in vitro HCC models. Our models represent multiple features of human HCC, including clonal origin, histopathological appearance and metastasis. We integrated transcriptomic data from the mouse models with human HCC data and identified four common human–mouse subtype clusters. The subtype clusters had distinct transcriptomic characteristics that aligned with the human histopathology. In a proof-of-principle analysis, we verified response to standard-of-care treatment and used a linked in vitro–in vivo pipeline to identify a promising therapeutic candidate, cladribine, that has not previously been linked to HCC treatment. Cladribine acts in a highly effective subtype-specific manner in combination with standard-of-care therapy.

7 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
FSFarzaneh Seyedshahi
Farzaneh Seyedshahi
KRKai Rakovic
Kai Rakovic
NPNicolas Poulain
Nicolas Poulain
AQAdalberto Claudio Quiros
Adalberto Claudio Quiros
IPIan R. Powley
Ian R. Powley
JQJohn Le Quesne
John Le Quesne
Mesothelioma is a highly lethal and poorly biologically understood disease which presents diagnostic challenges due to its morphological complexity. This study uses self-supervised AI (Artificial Intelligence) to map the histomorphological landscape of the disease. The resulting atlas consists of recurrent patterns identified from 3446 Hematoxylin and Eosin (H&E) stained images scanned from resected tumour slides. These patterns generate highly interpretable predictions, achieving state-of-the-art performance with 0.65 concordance index (c-index) for outcomes and 88% AUC in subtyping. Their clinical relevance is endorsed by comprehensive human pathological assessment. Furthermore, we characterise the molecular underpinnings of these diverse, meaningful, predictive patterns. Our approach both improves diagnosis and deepens our understanding of mesothelioma biology, highlighting the power of this self-learning method in clinical applications and scientific discovery.

16 October 2025 in bioRxiv
Verified
Preprint
Open access
LFLucas Farndale
Lucas Farndale
KRKai Rakovic
Kai Rakovic
IPIan R. Powley
Ian R. Powley
PHPhimmada Hatthakarnkul
Phimmada Hatthakarnkul
FSFarzaneh Seyedshahi
Farzaneh Seyedshahi
KYKe Yuan
Ke Yuan
Modern spatial proteomic methods, such as multiplex immunofluorescence (mIF) imaging, offer a data-rich view of spatial biology in intact tissues. However, interpreting its complexity is a major bottleneck, limiting its potential for biological discovery and clinical translation. Current computational methods often rely solely on segmentation-based analysis that discards crucial morphological information and are limited to testing pre-defined hypotheses. Here, we introduce a self-supervised learning (SSL) framework, HyPERSTAC, which integrates SSL and segmentation-based analysis to enable hypothesis-agnostic, context-aware discovery of biomarkers directly from mIF images. Our approach extracts rich feature representations that capture holistic architectural patterns, which integrate cellular morphology, marker interactions, and microenvironmental context without human supervision. Applying HyPERSTAC to close to 400,000 mIF tissue images from two cancer cohorts totalling over 1,800 patients, we show that SSL-derived features complement existing spatial analyses. Using HyPERSTAC to integrate SSL-derived features with segmentation-based neighbourhood analysis or the established spatial frameworks TRACERx-PHLEX and MuSpAn increased prognostic concordance in held-out patients. HyPERSTAC improves survival prediction for four SSL training methods, and two state-of-the-art foundation models. The method autonomously identified previously unknown and potentially clinically actionable biological patterns. In lung adenocarcinoma, these include a Ki67-mediated immune evasion phenotype, a subcellular pattern of GLB1 expression which aligns with low-grade EGFR -driven tumours, and distinct modes of tumour-immune interaction in PD-L1 + patients. We also find a regulatory T-cell-mediated immuno-suppressive environment promoting tumour budding in colorectal carcinoma. Our work shows that SSL can complement segmentation-based analysis, establishing HyPERSTAC as a powerful, scalable, explainable, and unbiased platform to decode tissue ecosystems without pre-defined hypotheses. This transforms high-plex imaging from a hypothesis-testing tool into a hypothesis-generating engine that can accelerate the discovery of next-generation spatial biomarkers. We release two large image datasets from LATTICe-A , creating the largest publicly available multiplex immunofluorescence patient cohort, with two panels totalling almost 6,000 images from 1,000 patients and accompanying survival data. This creates a new benchmark for the community and enables further biomarker discovery from these data.

12 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
HWHannah L Williams
Hannah L Williams
NPNicolas Poulain
Nicolas Poulain
IPIan Powley
Ian Powley
SMSilvia Martinelli
Silvia Martinelli
RBRobert Bielik
Robert Bielik
JQJohn Le Quesne
John Le Quesne
Adenocarcinoma of the lung (LUAD) is a common and highly lethal disease. Clinical grading of disease strongly predicts recurrence and survival after surgery and is determined by morphological assessment of histological growth patterns in resected tumours. The molecular basis of growth pattern is poorly understood at present, as are the mechanisms linking growth pattern to recurrence and death. Interestingly, the two archetypal lethal morphologies, solid and micropapillary patterns, are characterised by their biphasic appearance. Both have an epithelial fraction which is in direct stromal contact, and a fraction which is not. This morphological variance seems likely to represent plasticity, and to be causally linked to mechanisms of virulence. To investigate the gene expression changes related to growth pattern both intra- and intertumoral, we applied spatial transcriptomics (Nanostring GeoMx DSP) to tissue microarray specimens of primary resected human lung adenocarcinoma. Using a variety of region-of-interest (ROI) selection strategies, we sampled 160 pure epithelial ROIs across 7 distinct morphological features of LUAD from 51 patients. Analyses of gene expression reveal fundamental trajectories connecting growth patterns, and crucial modes of plasticity which underly high-risk morphologies. These modes suggest mechanisms for the origins of growth pattern and mechanisms of virulence. Our work highlights dramatic divergence in gene expression programmes between highly lethal but morphologically diverse modes of tumour growth. Furthermore, it provides an explanation for how microscopically localised hypoxia in the primary tumour helps to establish and maintain survival strategies which ultimately determine morphology-specific mechanisms of tumour metastasis, suggesting new therapeutic vulnerabilities.

17 January 2025 in Research Square
Verified
Preprint
Open access
PDF file
JQJohn Le Quesne
John Le Quesne
FSFarzaneh Seyedshahi
Farzaneh Seyedshahi
KRKai Rakovic
Kai Rakovic
NPNicolas Poulain
Nicolas Poulain
AQAdalberto Claudio Quiros
Adalberto Claudio Quiros
KYKe Yuan
Ke Yuan
Mesothelioma is a highly lethal and poorly biologically understood disease which presents diagnostic challenges due to its morphological complexity. This study uses self-supervised AI (Artificial Intelligence) to map the histomorphological landscape of the disease. The resulting atlas consists of recurrent patterns identified from 3446 Hematoxylin and Eosin (H&E) stained images scanned from resected tumour slides. These patterns generate highly interpretable predictions, achieving state-of-the-art performance with 0.65 concordance index (c-index) for outcomes and 85% AUC in subtyping. Their clinical relevance is endorsed by comprehensive human pathological assessment. Furthermore, we characterise the molecular underpinnings of these diverse, meaningful, predictive patterns. Our approach both improves diagnosis and deepens our understanding of mesothelioma biology, highlighting the power of this self-learning method in clinical applications and scientific discovery.